AI assistant
Natera, Inc. — Director's Dealing 2025
Dec 18, 2025
30253_dirs_2025-12-17_55c5da8a-81b1-413b-96f7-d53a34b81a5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2025-12-15
Reporting Person: Sheena Jonathan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Common Stock | G | 1060 | — | Disposed | 226036 | Direct |
| 2025-12-17 | Common Stock | S | 1592 | $226.5404 | Disposed | 224444 | Direct |
| 2025-12-17 | Common Stock | S | 1348 | $227.4355 | Disposed | 223096 | Direct |
| 2025-12-17 | Common Stock | S | 130 | $228.2831 | Disposed | 222966 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 23282 | Indirect |
| Common Stock | 23282 | Indirect |
Footnotes
F1: Represents a charitable contribution by the Reporting Person.
F2: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.94 to $226.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.96 to $227.84 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.98 to $228.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.